Pre-clinical efficacy and safety evaluation of MOv18 IgE, a novel class of antibody targeting alpha folate receptor

Project: Research

Project Details

StatusFinished
Effective start/end date1/06/201231/12/2016

Funding

  • CRUK Cancer Research UK: £22,000.00
  • CRUK Cancer Research UK: £18,000.00
  • CRUK Cancer Research UK: £59,928.00
  • CRUK Cancer Research UK: £72,463.00
  • CRUK Cancer Research UK: £15,120.00